Tendencias y factores asociados al consumo de tabaco en los ...
Tendencias y factores asociados al consumo de tabaco en los ...
Tendencias y factores asociados al consumo de tabaco en los ...
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Programas <strong>de</strong> cesación y opcionespara <strong>de</strong>jar <strong>de</strong> fumar24719. Nacion<strong>al</strong> Library of Medicine [sitio <strong>de</strong> Internet] Consultado el 15 <strong>de</strong> junio <strong>de</strong> 2004.Disponible <strong>en</strong>: http://www.nlm.nih.gov/medlineplus/spanish/druginfo/medmaster/a684056-es.html.20. Nicoret.com. Consultado el 15 <strong>de</strong> junio <strong>de</strong> 2004.Disponible <strong>en</strong>: http://www.nicoret.com/home/parte2/goma.htm.21. Nicorette® La Monografía <strong>de</strong> la Marca Nicotina, Aids Internacion<strong>al</strong>, 1992.22. "Meta-análisis <strong>de</strong> la eficacia <strong>de</strong> terapias <strong>de</strong> reemplazo <strong>de</strong> nicotina <strong>en</strong> la cesación <strong>de</strong>lcigarro", Silagy et <strong>al</strong>, The Lancet Vol 343, Enero 15, 1994.23. Nicoret.com. Consultado el 15 <strong>de</strong> junio <strong>de</strong> 2004.Disponible <strong>en</strong>: http://www.nicoret.com/home/parte2/parche.htm.24. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacem<strong>en</strong>t therapy forsmoking cessation. (Cochranre Review). En: The Cochrane Library, Issue 4 2002.Oxford:Update Software.25. H<strong>en</strong>ningfield JE. Nicotine medication for smoking cessation. N Engl J Med 1995;333:1196-1203.26. Daughton DM, Fortmann SP, Glover ED, et <strong>al</strong>. The smoking cessation efficacy of varyingdoses of nicotine patch <strong>de</strong>livery systems 4 to 5 years post-quit day. Prev Med 1999;28:113.27. Working group for the study of trans<strong>de</strong>rm<strong>al</strong> nicotine in pati<strong>en</strong>ts with coronary arterydisease. Nicotine replacem<strong>en</strong>t for pati<strong>en</strong>ts with coronary artery disease. Arch Intern Med1994; 154:989-995.28. B<strong>en</strong>owitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: Implications for nicotinereplacem<strong>en</strong>t therapy. J Am Coll Cardiol 1997; 29:1422-1431.29. Mahmarian JJ, Moye LA, Nasser GA, et <strong>al</strong>. Nicotine patch therapy in smoking cessationreduces the ext<strong>en</strong>t of exercise-induced myocardi<strong>al</strong> ischemia. J Am Coll Cardiol 1997;30:125.30. B<strong>en</strong>owitz NL. Nicotine replacem<strong>en</strong>t therapy during pregnancy. JAMA 1991; 266:3174-3177.31. Nicoret.com. Consultado el 15 <strong>de</strong> junio <strong>de</strong> 2004.Disponible <strong>en</strong>:http://www.nicoret.com/home/parte2/inh<strong>al</strong>ador.htm.32. Jor<strong>en</strong>by DE, Leischow SSJ, Ni<strong>de</strong>s MA, R<strong>en</strong>nard SI, Jonson JAA, Hughes AR, et <strong>al</strong>. Acontrolled tri<strong>al</strong> of sustained-release bupropion, a nicotine patch, or both for smokingcessation. N Engl J Med 1999; 340:685-691.33. Tonnes<strong>en</strong> P, Norregaard J, Mikkels<strong>en</strong> K, Jorg<strong>en</strong>s<strong>en</strong> S, Nilsson F. A double-blind tri<strong>al</strong> of anicotine inh<strong>al</strong>er for smoking cessation. JAMA 1993; 269:1268-1271.34. Hajek P, West R, Foulds,J, et <strong>al</strong>. Randomized comparative tri<strong>al</strong> of nicotine polacrilex, atrans<strong>de</strong>rm<strong>al</strong> patch, nas<strong>al</strong> spray, and an inh<strong>al</strong>er. Arch Intern Med 1999; 159:2033.35. Nicoret.com. Consultado el 15 <strong>de</strong> junio <strong>de</strong> 2004.Disponible <strong>en</strong>: http://www.nicoret.com/home/parte1/tipo.htm.36. Hays JT, Hurt RD, Rigotti NA, et <strong>al</strong>. Sustained-release bupropion for pharmacologicrelapse prev<strong>en</strong>tion after smoking cessation. A randomized, controlled tri<strong>al</strong>. Ann InternMed 2001; 135:423.37. Hurt RD, Sachs DPL, Glover ED, Offord KP, D<strong>al</strong>e LC, et <strong>al</strong>. A Comparison of sustainedreleasebuproprion and placebo for smoking cessation. N Engl J Med 1997; 337:1195.38. Jor<strong>en</strong>by DE, Leischow SSJ, Ni<strong>de</strong>s MA, R<strong>en</strong>nard SI, Jonson JAA, Hughes AR, et <strong>al</strong>. Acontrollled tri<strong>al</strong> of sustained-release bupropion, a nicotine patch, or both for smokingcessation. N Engl J Med 1999; 340:685-691.39. UIATLD News Bulletin on Tobacco and He<strong>al</strong>th 1998; 11: 33.40. Tapia-Conyer R, Cravioto P. Epi<strong>de</strong>miología <strong>de</strong>l Consumo <strong>de</strong> Tabaco. En: Las adicciones,dim<strong>en</strong>sión, impacto y perspectiva, 2a Ed. México, D.F.: Manu<strong>al</strong> Mo<strong>de</strong>rno, 2001.
Change language